Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations

Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations

Dyslipidemia, diabetes, obesity and hypertension are common metabolic diseases. In the last decades, unhealthy lifestyle and aging have leads to an increased incidence of these diseases, increasing morbidity and mortality by cardiovascular causes. The treatment of metabolic diseases includes life-st...

Full description

Bibliographic Details
Main Authors:	Rosario Dominguez Crespo Hirata, Alvaro Cerda, Fabiana Dalla Vecchia Genvigir, Mario Hiroyuki Hirata
Format:	Article
Language:	English
Published:	Universidade de São Paulo 2018-11-01
Series:	Brazilian Journal of Pharmaceutical Sciences
Subjects:	Pharmacogenetics Metabolic diseases Gene polymorphism Drug response
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502018000700404&lng=en&tlng=en

Similar Items

PHARMACOGENETICS – THE FUTURE OF THE DRUG THERAPY
by: Slobodan Jankovic, et al.
Published: (2007-10-01)

Pharmacogenetics of OATP Transporters Reveals That SLCO1B1 c.388A>G Variant Is Determinant of Increased Atorvastatin Response
by: Rosario D. C. Hirata, et al.
Published: (2011-09-01)

Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes
by: Rosario Dominguez Crespo Hirata, et al.
Published: (2023-01-01)

Pharmacogenetics in schizophrenia: a review of clozapine studies
by: Fabiana Barzotti Kohlrausch
Published: (2013-09-01)

Pharmacogenetic Testing: A Tool for Personalized Drug Therapy Optimization
by: Kristina A. Malsagova, et al.
Published: (2020-12-01)

Developments in pharmacogenetics, pharmacogenomics, and personalized medicine
by: Francisco Abad-Santos, et al.
Published: (2024-02-01)

Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant Recipients
by: Antony Brayan Campos-Salazar, et al.
Published: (2018-11-01)

Principles of pharmacogenetics and pharmacogenomics /
by: Altman, Russ B. 205766, et al.
Published: (2012)

Pharmacogenetics of cardiovascular drugs
by: Pajović Vladislav, et al.
Published: (2023-01-01)

Pharmacogenetics in Clinical Practice
by: Hana Bakhouche, et al.
Published: (2012-01-01)

Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications
by: Zhang F, et al.
Published: (2019-07-01)

Application of pharmacogenetics in oncology
by: Nelly N. Miteva-Marcheva, et al.
Published: (2020-08-01)

Pharmacogenetics of Drugs Used in the Treatment of Cancers
by: Beata Franczyk, et al.
Published: (2022-02-01)

Pharmacogenetics of antiretroviral drugs
by: Dragović Gordana, et al.
Published: (2012-01-01)

Pharmacogenetics from ethno-cultural perspectives
by: Chee Ng, et al.
Published: (2010-12-01)

Establishment of a Pharmacogenetics Service Focused on Optimizing Existing Pharmacogenetic Testing at a Large Academic Health Center
by: Amy L. Pasternak, et al.
Published: (2020-10-01)

Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients
by: Valentina Urzì Brancati, et al.
Published: (2022-07-01)

New approaches to pharmacogenetics of drug-induced hyperprolactinemia in patients with schizophrenia
by: S. A. Ivanova
Published: (2019-12-01)

Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research
by: Aizati N. A. Daud, et al.
Published: (2017-04-01)

Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy
by: Alina A. Bagdasaryan, et al.
Published: (2022-11-01)

New bearings in pharmacotherapeutic strategies: Pharmacogenetics and gene therapy
by: Grbović Leposava, et al.
Published: (2007-01-01)

Knowledge and Attitudes of Pharmacogenetics Among Canadian Nurses: Implications for Nursing Education
by: Noopur Swadas, et al.
Published: (2022-06-01)

Genetic polymorphisms and drug metabolism
by: Vita Dolžan
Published: (2007-12-01)

Analysis of the complications of endocrine therapy with tamoxifen in breast cancer: clinical and pharmacogenetic aspects. Prospective pharmacogenetic cohort study
by: Marina I. Savelyeva, et al.
Published: (2022-11-01)

Importance of Pharmacogenetics and Drug–Drug Interactions in a Kidney Transplanted Patient
by: Julia Concha, et al.
Published: (2023-07-01)

Type 2 diabetes mellitus: Clinical aspects of genetics, nutrigenetics, and pharmacogenetics
by: A S Ametov, et al.
Published: (2015-08-01)

Pharmacogenetics of FSH Action in the Male
by: Maria Schubert, et al.
Published: (2019-02-01)

Severe Vincristine-Induced Neuropathic Pain: A Case Report with Pharmacogenetic Analysis and Literature Review
by: Hu YH, et al.
Published: (2022-12-01)

Role of pharmacogenetic factors in the development of side effects of methotrexate in the treatment of malignant tumors: A review
by: Timur T. Valiev, et al.
Published: (2021-12-01)

Pharmacogenetic Variation and Its Clinical Relevance in a Latin American Rural Population
by: Jordi Olloquequi, et al.
Published: (2022-10-01)

Pharmacogenetics of antidepressants
by: Concetta eCrisafulli, et al.
Published: (2011-02-01)

OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
by: Miles Douglas Thompson, et al.
Published: (2014-05-01)

Some pharmacogenetic aspects of the <i>ABCB1</i> gene in lopinavir / ritonavir concentration variability in children with HIV infection: A pilot study
by: A. Yu. Sambyalova, et al.
Published: (2022-12-01)

Pharmacogenetics of antidepressant drugs: An update
by: Crisafulli Concetta, et al.
Published: (2014-01-01)

Pharmacogenetics of breast cancer : towards the individualization of therapy /
by: Leyland-Jones, Brian
Published: (2008)

Pharmacogenetic Study of the Impact of <i>ABCB1</i> Single Nucleotide Polymorphisms on the Response to Cyclosporine in Psoriasis Patients
by: Alexandr Chernov, et al.
Published: (2022-11-01)

The Utility of Pharmacogenetics Testing in Psychiatric Populations
by: Gesche Jürgens
Published: (2021-12-01)

Pharmacogenetics and adhd treatment outcomes in the danish population-based IPSYCH sample
by: C. Lunenburg, et al.
Published: (2021-04-01)

Pharmacogenetics, pharmacogenomics and airway disease
by: Hall Ian P
Published: (2001-11-01)

EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY
by: A. V. Semenov, et al.
Published: (2016-01-01)